Beaumont RCSI Cancer Conference focuses on improving healthcare equity in cancer treatment

  • Research
  • General news
L-R: Professor Leonie Young, David Sweeney, Claire Noonan, Professor Arnold Hill, Sara Long, Professor Patrick Morris, Professor Cathal Kelly.

Cancer experts will convene today for the 2024 Beaumont RCSI Cancer Centre Conference at the RCSI Education and Research Centre in Beaumont Hospital, Dublin. This year’s theme, ‘Cancer Care for All: Understanding Populations to Improve Outcomes’, aims to address vital topics such as healthcare outcomes, and equity and access in cancer diagnostics and research.

The annual conference brings together healthcare professionals, academics and key stakeholders to discuss the latest advancements in cancer care. This year’s focus is particularly on understanding the diverse needs of patient populations to enhance the effectiveness of cancer treatment across the board. 

Professor Leonie Young, Scientific Director of the Beaumont RCSI Cancer Centre, commented on this year’s theme: “Understanding the diverse backgrounds and specific needs of our patients is crucial in tailoring effective cancer treatments. This conference serves as an important forum to share insights and exchange ideas that will not only advance cancer care, but also ensure it is accessible and equitable for all.”  

Attendees will hear from a distinguished lineup of speakers including Professor Willie Hamilton, Professor of Primary Care Diagnostics at the University of Exeter and Cancer Research UK; Professor Edward Gregg, Head of the School of Population Health at RCSI; Professor Jarushka Naidoo, Professor of Medical Oncology at RCSI and Consultant Medical Oncologist at Beaumont RCSI Cancer Centre; and Professor Mark Lawler, Professor of Digital Health at Queen's University Belfast. Siobhan Gaynor, a member of the Patient Consultative Committee at Cancer Trials Ireland, will also share invaluable insights from the patient’s perspective. 

Sara Long, the newly appointed regional executive officer for the Health Service Executive (HSE) Dublin North East will deliver the opening address, highlighting the ongoing commitment of the HSE to supporting cancer research and treatment initiatives. 

Speaking about the event, Professor Patrick Morris, Medical Director of the Beaumont RCSI Cancer Centre, said: “This conference reflects the core approach of the Beaumont RCSI Cancer Centre, where clinicians and scientists collaborate closely to provide individualised and quality care. Our collective efforts are aimed at improving patient care and setting new standards in cancer treatment through innovation and teamwork.” 

The Beaumont RCSI Cancer Centre is a partnership between Ireland’s leading healthcare professionals, academics, biologists, epidemiologists and statisticians across the disciplines of medicine, radiation, surgery and palliative care. Specialising in a broad spectrum of cancers, the centre is at the forefront of integrating research findings into practical treatment plans that benefit patients directly.